Pearl River Capital, LLC Medtronic PLC Transaction History

Pearl River Capital, LLC

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$78.71 - $87.02 $9.53 Million - $10.5 Million	121,092 New	121,092 $9.53 Million
Q4 2023 Feb 13, 2024	BUY	$69.43 - $83.43 $834,826 - $1 Million	12,024 New	12,024 $990,000
Q2 2023 Aug 11, 2023	BUY	$79.47 - $91.38 $2.02 Million - $2.32 Million	25,370 New	25,370 $2.24 Million
Q3 2022 Nov 14, 2022	BUY	$80.75 - $95.31 $1.27 Million - $1.49 Million	15,670 New	15,670 $1.27 Million
Q1 2022 May 13, 2022	SELL	$100.58 - $112.38 $3.6 Million - $4.02 Million	-35,750 Closed	0 $0
Q4 2021 Feb 11, 2022	BUY	$99.53 - $127.75 $2.95 Million - $3.78 Million	29,603 Added 481.58%	35,750 $3.7 Million
Q3 2021 Nov 12, 2021	SELL	$122.75 - $135.17 $446,319 - $491,478	-3,636 Reduced 37.17%	6,147 $771,000
Q2 2021 Aug 13, 2021	SELL	$118.19 - $131.5 $1.26 Million - $1.4 Million	-10,658 Reduced 52.14%	9,783 $1.21 Million
Q1 2021 May 14, 2021	BUY	$111.18 - $119.74 $1.88 Million - $2.02 Million	16,893 Added 476.13%	20,441 $2.42 Million
Q4 2020 Feb 12, 2021	BUY	$100.57 - $117.14 $61,247 - $71,338	609 Added 20.72%	3,548 $416,000
Q4 2019 Feb 12, 2020	BUY	$104.49 - $114.54 $307,096 - $336,633	2,939 New	2,939 $333,000

2,291

1.02B

8.06M

7.17M

Ticker MDT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,329,149,952
Market Cap $122B
Description
Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac...

Get notified when there are updates to the investment portfolio of Pearl River Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Pearl River Capital, LLC with notifications on news.